E-LIB Suche - Ergebnisse für: Dvortsin, E.

1

EE304 Cost-Effectiveness of Volume Computed Tomography in L..:

Pan, X ; Dvortsin, E ; Baldwin, DR...
Value in Health. 25 (2022) 12 - p. S113 , 2022

Link: https://doi.org/10.1016/..

2

P1.02-03 Budget Impact Analysis of Volume CT Lung Cancer Sc..:

Pan, X. ; Dvortsin, E. ; Aerts, J....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S99 , 2022

Link: https://doi.org/10.1016/..

3

PCN213 Health IMPACT of Optimizing the Time to Patient Acce..:

Wolters, S. ; Dvortsin, E. ; Jansen, C....
Value in Health. 23 (2020) - p. S460-S461 , 2020

Link: https://doi.org/10.1016/..

4

PIN28 Rotavirus Vaccination of Infants Delayed and Limited ..:

Zeevat, F. ; Dvortsin, E. ; Wondimu, A...
Value in Health. 23 (2020) - p. S548 , 2020

Link: https://doi.org/10.1016/..

5

PDB15 THE COST OF HYPOGLYCAEMIA IN TYPE 2 DIABETES MELLITUS..:

de Jong, L. ; Westerink, L. ; Dvortsin, E..
Value in Health. 22 (2019) - p. S574 , 2019

Link: https://doi.org/10.1016/..

6

PDB39 - EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH ..:

Voorhaar, M. ; Nurkanovic, L. ; Ustyugova, A.V...
Value in Health. 21 (2018) - p. S124 , 2018

Link: https://doi.org/10.1016/..

7

Costs of Clinical Events in Diabetes Type 2 Patients in the..:

van Schoonhoven, A ; de Vries, M ; Gout-Zwart, J...
Value in Health. 20 (2017) 9 - p. A485-A486 , 2017

Link: https://doi.org/10.1016/..

8

10 Years Of Reimbursement Decisions In The Netherlands: An ..:

Dvortsin, E ; Novak, A ; Postma, MJ
Value in Health. 20 (2017) 9 - p. A678 , 2017

Link: https://doi.org/10.1016/..

9

Deciding On Universal Rotavirus Vaccination In The Netherla..:

Dvortsin, E ; Zeevat, F ; Novak, A.
Value in Health. 20 (2017) 9 - p. A798 , 2017

Link: https://doi.org/10.1016/..

10

Economic Burden Of Vaccine Preventable Infectious Diseases ..:

Dvortsin, E ; Connolly, M ; Standaert, B.
Value in Health. 20 (2017) 9 - p. A796 , 2017

Link: https://doi.org/10.1016/..

11

Burden of early and advanced breast cancer in the Netherlan..:

Vondeling, G. ; Dvortsin, E. ; Rozenbaum, M...
European Journal of Cancer. 72 (2017) - p. S15 , 2017

Link: https://doi.org/10.1016/..

12

Trends in Health Technology Assessments since the Introduct..:

Dvortsin, E ; Vondeling, G ; van der Woude, T.
Value in Health. 19 (2016) 7 - p. A833 , 2016

Link: https://doi.org/10.1016/..

13

Comparative Cost-Effectiveness of Drugs in Early Versus Lat..:

Dvortsin, E ; Eijssen, EM ; van Brussel, J..
Value in Health. 18 (2015) 7 - p. A487 , 2015

Link: https://doi.org/10.1016/..

14

Burden of early, advanced and metastatic breast cancer in T..:

Vondeling, G. T. ; Menezes, G. L. ; Dvortsin, E. P....
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

15

Dabigatran for the Treatment and Secondary Prevention of Ve..:

Stevanović, J. ; de Jong, L. A. ; Kappelhoff, B. S....
PLOS ONE. 11 (2016) 10 - p. e0163550 , 2016

Link: https://doi.org/10.1371/..